Dec 7, 2022 5:00 pm EST Top-line Results from Phase 3 RELIANCE I Trial for REL-1017 as an Adjunctive Treatment for Major Depressive Disorder Conference Call View
Feb 23, 2022 8:30 am EST Relmada Results of Human Abuse Potential Study of REL-1017 vs. Ketamine View
Jul 27, 2021 8:30 am EST Top-Line Results of Study Evaluating REL-1017 vs Oxycodone for Abuse Potential View
Apr 27 – Apr 30, 2021 American Society for Pharmacology and Experimental Therapeutics Annual Meeting at Experimental Biology 2021 View
Oct 15, 2019 8:30 am EST Conference Call to Discuss Results of Phase 2 Study of REL-1017 for Treatment Resistant Depression View
Dec 11, 2018 5:30 pm EST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) View
